Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives $19.17 Consensus PT from Analysts

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $19.17.

A number of brokerages have weighed in on CCAP. Keefe, Bruyette & Woods raised their target price on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research report on Monday, November 25th. LADENBURG THALM/SH SH initiated coverage on Crescent Capital BDC in a report on Monday, September 30th. They set a “buy” rating and a $20.00 price objective on the stock.

Institutional Investors Weigh In On Crescent Capital BDC

Institutional investors have recently made changes to their positions in the stock. Point72 Asset Management L.P. bought a new position in shares of Crescent Capital BDC during the second quarter worth about $90,000. XTX Topco Ltd acquired a new position in shares of Crescent Capital BDC in the 2nd quarter worth approximately $195,000. Catalina Capital Group LLC acquired a new position in shares of Crescent Capital BDC in the 2nd quarter worth approximately $220,000. Cubist Systematic Strategies LLC bought a new stake in shares of Crescent Capital BDC in the 2nd quarter valued at $346,000. Finally, Van ECK Associates Corp increased its position in shares of Crescent Capital BDC by 136.1% during the second quarter. Van ECK Associates Corp now owns 26,521 shares of the company’s stock worth $498,000 after buying an additional 15,288 shares during the period. Institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Stock Up 0.9 %

CCAP stock opened at $19.52 on Friday. The stock has a market capitalization of $723.45 million, a P/E ratio of 7.65 and a beta of 0.82. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14. The firm has a 50-day moving average price of $18.92 and a 200-day moving average price of $18.69. Crescent Capital BDC has a 12 month low of $15.91 and a 12 month high of $20.03.

Crescent Capital BDC Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st will be issued a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 8.61%. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.07. The ex-dividend date is Tuesday, December 31st. Crescent Capital BDC’s dividend payout ratio is presently 65.88%.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.